Regencell Bioscience Holdings (Regencell Bioscience Holdings) EV-to-EBITDA

Regencell Bioscience Holdings Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
EV-to-EBITDA					-	-	-61.98	-	-52.45

For the Drug Manufacturers - Specialty & Generic subindustry, Regencell Bioscience Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

For the Drug Manufacturers industry and Healthcare sector, Regencell Bioscience Holdings's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Regencell Bioscience Holdings's EV-to-EBITDA falls into.

Regencell Bioscience Holdings EV-to-EBITDA Calculation

Regencell Bioscience Holdings's EV-to-EBITDA for today is calculated as:

Regencell Bioscience Holdings's current Enterprise Value is $56.83 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Regencell Bioscience Holdings's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was $-6.27 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Regencell Bioscience Holdings  (NAS:RGC) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Regencell Bioscience Holdings's PE Ratio for today is calculated as:

Regencell Bioscience Holdings's share price for today is $5.55.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Regencell Bioscience Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was $-0.450.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Regencell Bioscience Holdings EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Regencell Bioscience Holdings's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Regencell Bioscience Holdings (Regencell Bioscience Holdings) Business Description